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Background:  Diastolic dysfunction without systolic dysfunction is common in patients undergoing outpatient echocardiography. 
Randomized trials have demonstrated no mortality benefit from angiotensin converting enzyme inhibitors (ACEi) or angiotensin receptor 
blockers (ARB) in heart failure with preserved ejection fraction. However, the benefit of ACEi/ARB therapy for early echocardigraphic 
evidence of diastolic dysfunction is not established.
methods:  491 consecutive patients undergoing outpatient echocardiograms from 2010 to 2011 were considered for study inclusion. 
Patients with systolic dysfunction and normal diastolic function were excluded. Of the remaining 290 (59.4%) patients with diastolic 
dysfunction, 158 (54.5%) were on an ACEi or ARB and 132 (45.5%) were not. All-cause mortality was assessed using the electronic 
medical record at an average follow up of 3.6 years.
results:  Of the 290 patients included in the analysis, 270 (92.5%) had mild diastolic dysfunction and 41 (14.1%) had a previous 
diagnosis of heart failure. There were 36 deaths during the study period representing 12.4% of patients. Patients on an ACEi or ARB had a 
significantly lower mortality rate (8.9%) compared to those not on therapy (8.9 vs. 16.7%, HR 0.465 [95% CI: 0.234 to .924], p=0.029).
conclusion:  Patients with evidence of pure diastolic dysfunction on outpatient echocardiogram had improved long-term mortality when on 
ACEi/ARB therapy. This study is hypothesis generating and further studies are needed. 
